OTHER MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES IN ATC
- amivantamab (RYBREVANT)
- belantamab mafodotin (BLENREP)
- blinatumomab (BLINCYTO)
- brentuximab vedotin (ADCETRIS)
- dinutuximab (UNITUXIN)
- elranatamab (ELREXFIO)
- enfortumab vedotin (PADCEV)
- epcoritamab (EPKINLY)
- gemtuzumab ozogamicin (MYLOTARG)
- glofitamab (COLUMVI)
- ipilimumab (YERVOY)
- mirvetuximab soravtansine (ELAHERE)
- mogamulizumab (POTELIGEO)
- polatuzumab vedotin (POLIVY)
- sacituzumab govitecan (TRODELVY)
- tafasitamab (MINJUVI)
- talquetamab (TALVEY)
- tarlatamab (IMDELLTRA)
- teclistamab (TECVAYLI)
- tremelimumab (IMJUDO)
- zolbetuximab (VYLOY)
Using Health Canada Drug Database
updated on 11Apr2026.